论文部分内容阅读
目的评价奥拉西坦用于改善高血压脑出血患者认知功能障碍和生活自理能力的临床疗效。方法高血压脑出血患者病例总数84例,随机分为观察组(给予奥拉西坦800mg/次,2次/d治疗)和对照组(给予安慰剂治疗)各42例。运用简易精神状态量表(mini mental state examination,MMSE)和巴氏指数(Barthel index,BI)以及神经功能缺损量表(National Institutes of Health Stroke Scale,NIHSS)对治疗前后观察组和对照组患者进行评分。结果观察组经过奥拉西坦治疗,MMSE和BI评分明显增加,NIHSS评分明显降低,且与治疗前相比差异有统计学意义(P<0.01);对照组治疗前后的各项评均分无显著性差异(P>0.05);治疗后观察组与对照组组间比较,各项评分均有显著性差异(P<0.01)。结论奥拉西坦可用于改善高血压脑出血患者大脑认知功能和生活自理能力,药物安全有效。
Objective To evaluate the clinical efficacy of oxiracetam in improving cognitive dysfunction and self-care ability in patients with hypertensive intracerebral hemorrhage. Methods A total of 84 patients with hypertensive intracerebral hemorrhage were randomly divided into observation group (given oxiracetam 800mg / time, twice daily) and control group (given placebo). The patients in the observation group and the control group before and after treatment were treated with mini mental state examination (MMSE), Barthel index (BI) and National Institutes of Health Stroke Scale (NIHSS) score. Results Oxiracetam treatment in observation group significantly increased the score of MMSE and BI, NIHSS score was significantly lower than that before treatment, and the difference was statistically significant (P <0.01); before and after treatment in the control group, (P> 0.05). After treatment, the scores of the observation group and the control group were significantly different (P <0.01). Conclusion Oxiracetam can be used to improve cognitive function and self-care ability in patients with hypertensive intracerebral hemorrhage. The drug is safe and effective.